BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23863647)

  • 1. [Outcomes of advanced gastric cancer patients treated with chemoradiation therapy].
    Ishigami S; Arigami T; Uenosono Y; Okumura H; Uchikado Y; Owaki T; Kijima Y; Nakajo A; Maemura K; Ueno S; Hokita S; Hiraki Y; Nakajo M; Natsugoe S
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):727-31. PubMed ID: 23863647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J; Pang QS; Wang P; Wang J; Wang W
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study for preoperative concurrent chemoradiotherapy with S-1 and cisplatin for locally advanced gastric cancer.
    Chung MJ; Kim H; Jung YS; Shin SK; Hyung WJ; Noh SH; Seong J; Lee YC; Song SY
    Hepatogastroenterology; 2013; 60(122):382-6. PubMed ID: 23858558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection.
    Lim SB; Yu CS; Hong YS; Kim TW; Kim JH; Kim JC
    J Surg Oncol; 2012 Nov; 106(6):659-66. PubMed ID: 22674581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
    Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
    Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection.
    Kim TH; Park SR; Ryu KW; Kim YW; Bae JM; Lee JH; Choi IJ; Kim YJ; Kim DY
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e585-92. PubMed ID: 22975616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
    Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
    Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.
    Kim MM; Mansfield PF; Das P; Janjan NA; Badgwell BD; Phan AT; Delclos ME; Maru D; Ajani JA; Crane CH; Krishnan S
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):167-72. PubMed ID: 18406886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
    Borghesi S; Hawkins MA; Tait D
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):221-6. PubMed ID: 18248970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus Cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancer.
    Niho S; Kubota K; Nihei K; Sekine I; Sumi M; Sekiguchi R; Funai J; Enatsu S; Ohe Y; Tamura T
    Clin Lung Cancer; 2013 Jan; 14(1):62-9. PubMed ID: 22633219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.
    Miyamoto DT; Mamon HJ; Ryan DP; Willett CG; Ancukiewicz M; Kobayashi WK; Blaszkowsky L; Fernandez-del Castillo C; Hong TS
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1171-7. PubMed ID: 19800182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical Oncology.
    Kucukoner M; Isikdogan A; Arpaci E; Bilici M; Uncu D; Cetin B; Dane F; Inane M; Kaplan MA; Cayir K; Yetisyigit T; Ozdemir N; Inal A; Aksoy S; Alkis N; Tekin SB; Eroglu C; Turhal S; Benekli M; Buyukberber S
    Hepatogastroenterology; 2012 Oct; 59(119):2343-7. PubMed ID: 22389301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
    Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Dec; 35(6):533-6. PubMed ID: 21659832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
    Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
    Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.